Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Cancer of the Cervix
ClinicalTrials.gov recordTREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Similar to other gynecologic malignancies, the evidence to support surveillance after initial management of vaginal cancer is weak because of a lack of randomized or prospective clinical studies.[9] There is no reliable evidence that routine cytological or imaging procedures in patients improves health outcomes beyond what is achieved by careful physical examination and assessment of new symptoms. Therefore, outside the investigational setting, imaging procedures may be reserved for patients in whom physical examination or symptoms raise clinical suspicion of a recurrence or progression.
Sources: 9
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Because vaginal cancer is rare, studies are limited to retrospective case series, usually from single-referral institutions.[Level of evidence C2] During the long span of time covered by these case series, available staging tests and radiation techniques often changed, including the shift to high-energy accelerators and conformal and intensity-modulated radiation therapy.[1,2] Comparing treatment approaches is further complicated by the frequent failure of investigators to provide precise staging criteria (particularly for stage I vs. stage II disease) or criteria for the choice of treatment modality. This has led to a broad range of reported disease control and survival rates for any given stage and treatment modality.[3]
Sources: Level of evidence C2 · 1 · 2 · 3
The following factors should be considered when planning treatment for vaginal cancer:
Stage and size of the lesion.
Ability to retain a functional vagina.
Presence or absence of the uterus.
Whether the patient has received previous pelvic radiation therapy.
Whether the lymphatics drain to pelvic or inguinal nodes or both, depending on tumor location.
Proximity of the vagina to the bladder or rectum. This limits surgical treatment options and increases short-term and long-term surgical complications and functional deficits.
Proximity to radiosensitive organs or organs that preclude radical resection without unacceptable functional deficits (e.g., bladder, rectum, urethra).
Rectovaginal fistulas.
Vesicovaginal fistulas.
Rectal or vaginal strictures.
Cystitis.
Proctitis.
Premature menopause from ovarian damage.
Soft tissue or bone necrosis.
Management of the extremely rare vaginal clear cell carcinoma is similar to the management of squamous cell carcinoma. However, techniques that preserve vaginal and ovarian function should be strongly considered during treatment planning, given the young age of the patients at diagnosis.[4]
Sources: 4
| Stage (FIGO Staging System) | Treatment Options | |
|---|---|---|
| FIGO = Fédération Internationale de Gynécologie et d’Obstétrique; SCC = squamous cell carcinoma; VaIN = vaginal intraepithelial neoplasia. | ||
| VaIN (this stage is not recognized by FIGO) | Laser therapy | |
| Wide local excision | ||
| Vaginectomy | ||
| Intravaginal chemotherapy | ||
| Intracavitary radiation therapy | ||
| Imiquimod | ||
| Stage I vaginal cancer | SCC | Radiation therapy |
| Surgery | ||
| Adenocarcinoma | Surgery | |
| Radiation therapy | ||
| Combined local therapy | ||
| Stages II, III, and IVa vaginal cancer (SCC and adenocarcinoma) | Radiation therapy | |
| Surgery | ||
| Chemoradiation | ||
| Stage IVb vaginal cancer (SCC and adenocarcinoma) | Radiation therapy | |
Sources: FIGO · Laser therapy · Wide local excision · Vaginectomy · Intravaginal chemotherapy · Intracavitary radiation therapy · Imiquimod · Radiation therapy · Surgery · Surgery · Radiation therapy · Combined local therapy · Radiation therapy · Surgery · Chemoradiation · Radiation therapy
For patients with early-stage vaginal carcinoma, radiation therapy, surgery, or a combination of these treatments are standard. Data from randomized trials are lacking, and the choice of therapy is generally determined by institutional experience and the factors listed above.[3]
Sources: factors listed above · 3
For patients with stages III and IVa disease, radiation therapy is standard and includes external-beam radiation therapy (EBRT), alone or with brachytherapy. Regional lymph nodes are included in the radiation portal. When used alone, EBRT involves a tumor dose of 65 Gy to 70 Gy, using shrinking fields, delivered within 6 to 7 weeks. Intracavitary brachytherapy provides insufficient dose penetration for locally advanced tumors, so interstitial brachytherapy is used if brachytherapy is given.[3,5]
For patients with stage IVb or recurrent disease that cannot be managed with local treatments, current therapy is inadequate. No established anticancer drugs have demonstrated proven clinical benefit, although patients are often treated with regimens used to treat cervical cancer. Concurrent chemotherapy, using fluorouracil or cisplatin-based therapy, and radiation are sometimes advocated, based solely on extrapolation from cervical cancer management strategies.[6-8] Evidence is limited to small case series and the incremental impact on survival and local control is not well defined.[Level of evidence C3]
Sources: 6 · 8 · Level of evidence C3
Local control is a problem with bulky tumors. Some investigators have also used concurrent chemotherapy with agents such as cisplatin, bleomycin, mitomycin, floxuridine, and vincristine without improved outcomes.[1] It is an extrapolation from treatment approaches used in cervical cancer, based on shared etiologic and risk factors.
Sources: 1
Because vaginal cancer is rare, these patients are candidates for clinical trials of anticancer drugs and/or radiosensitizers to attempt to improve survival or local control. Discussion of clinical trials should be considered with eligible patients. Information about ongoing clinical trials is available from the NCI website.
Sources: NCI website
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
The DPYD gene encodes an enzyme that catabolizes pyrimidines and fluoropyrimidines, like capecitabine and fluorouracil. An estimated 1% to 2% of the population has germline pathogenic variants in DPYD, which lead to reduced DPD protein function and an accumulation of pyrimidines and fluoropyrimidines in the body.[9,10] Patients with the DPYD*2A variant who receive fluoropyrimidines may experience severe, life-threatening toxicities that are sometimes fatal. Many other DPYD variants have been identified, with a range of clinical effects.[9-11] Fluoropyrimidine avoidance or a dose reduction of 50% may be recommended based on the patient's DPYD genotype and number of functioning DPYD alleles.[12-14] DPYD genetic testing costs less than $200, but insurance coverage varies due to a lack of national guidelines.[15] In addition, testing may delay therapy by 2 weeks, which would not be advisable in urgent situations. This controversial issue requires further evaluation.[16]
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Vaginal intraepithelial neoplasia (VaIN), the presence of noninvasive squamous cell atypia, is classified by the degree of involvement of the epithelium, as follows:
VaIN 1 is defined as involvement of the upper one-third of the epithelial thickness.
VaIN 2 is defined as involvement of the upper two-thirds of the epithelial thickness.
VaIN 3 is defined as involvement of more than two-thirds of the epithelial thickness. VaIN 3 lesions that involve the full thickness of the epithelium are called carcinoma in situ.
VaIN is associated with a high rate of human papillomavirus (HPV) infection and is thought to have an etiology that is similar to that of cervical intraepithelial neoplasia (CIN).[1-3]
The cervix and vulva are carefully evaluated because vaginal carcinoma in situ is associated with other genital neoplasia, and in some cases, may be an extension of CIN. Vaginal carcinoma in situ is often multifocal and commonly occurs in the vaginal vault. For more information, see Cervical Cancer Treatment.
Sources: Cervical Cancer Treatment
The extent and type of surgical treatment needed is dependent upon anatomical location, evidence of multifocality, general patient comorbidities, and other specific factors (e.g., anatomical distortion of vaginal vault from prior hysterectomy).[4]
Sources: 4
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
The following treatments have not been directly compared in randomized trials, so their relative efficacy is uncertain.[Level of evidence C3]
Sources: Level of evidence C3
Treatment options for VaIN include:
Sources: VaIN
Laser therapy [5] after biopsy to rule out invasive components that could be missed with this treatment approach.
Sources: 5
Wide local excision with or without skin grafting.[6]
Sources: 6
Partial or total vaginectomy, with skin grafting for multifocal or extensive disease.[7]
Sources: 7
Intravaginal chemotherapy with 5% fluorouracil (5-FU) cream. This option may be useful in the setting of multifocal lesions.[5,8]
Intracavitary radiation therapy.[9,10] Because of its attendant toxicity and inherent carcinogenicity, this treatment is primarily used in the setting of multifocal or recurrent disease, or when the risk of surgery is high.[1] The entire vaginal mucosa is usually treated.[11]
Imiquimod cream 5%, an immune stimulant used to treat genital warts, is an additional topical therapy that has a reported complete clinical response rate of 50% to 86% in small case series of patients with multifocal high-grade HPV-associated VaIN 2 and VaIN 3.[12] However, it is investigational, and it may have only short-lived efficacy.[13]
Women with VaIN 1 can usually be observed carefully without ablative or surgical treatment because the lesions often regress spontaneously. VaIN 2, the intermediate grade, is managed by careful observation or initial treatment. Although the natural history of VaIN is not precisely known because of its rarity, patients with VaIN 3 are presumed to be at substantial risk of progression to invasive cancer and are treated immediately. Lesions with hyperkeratosis respond better to excision or laser vaporization than to 5-FU.[4]
Sources: 4
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
The treatment options for stage I vaginal cancer have not been directly compared in randomized trials.[Level of evidence C2] Because of differences in patient selection, expertise in treating local disease, and staging criteria, it is difficult to determine whether there are differences in disease control rates.
Sources: Level of evidence C2
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Treatment options for stage I SCC of the vagina superficial lesions less than 0.5 cm thick include:
Sources: stage I SCC of the vagina
Radiation therapy.[1-4]
These tumors may respond to intracavitary brachytherapy alone,[1] but treatment usually begins with external-beam radiation therapy (EBRT).[2]
EBRT is required for bulky lesions or lesions that encompass the entire vagina.[1] For lesions in the lower third of the vagina, elective radiation therapy is often administered to the patient's pelvic and/or inguinal lymph nodes.[1,2]
Surgery.[5]
Sources: 5
Surgery.[5]
Wide local excision or total vaginectomy with vaginal reconstruction may be performed, especially in lesions of the upper vagina. In cases with close or positive surgical margins, adjuvant radiation therapy is often added.[6]
Sources: 6
Treatment options for stage I SCC of the vagina lesions more than 0.5 cm thick include:
Sources: stage I SCC of the vagina
Surgery.[5]
Sources: 5
Surgery.[5]
For lesions in the upper third of the vagina, radical vaginectomy and pelvic lymphadenectomy should be considered. Construction of a neovagina may be performed if feasible and if desired by the patient.[6,7]
In lesions of the lower third, inguinal lymphadenectomy should be considered. In cases with close or positive surgical margins, adjuvant radiation therapy should be considered.[6]
Sources: 6
Radiation therapy.[1-4]
EBRT [2] and/or combination of interstitial and intracavitary radiation therapy may be administered to a dose of at least 75 Gy to the primary tumor.[1,8]
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Treatment options for stage I adenocarcinoma of the vagina include:
Sources: stage I adenocarcinoma of the vagina
Surgery.
Surgery.
Total radical vaginectomy and hysterectomy with lymph node dissection are indicated because the tumor spreads subepithelially.
The deep pelvic lymph nodes are dissected if the lesion invades the upper vagina, and the inguinal lymph nodes are removed if the lesion originates in the lower vagina.
Construction of a neovagina may be performed if feasible and if desired by the patient.[6]
Sources: 6
In cases with close or positive surgical margins, adjuvant radiation therapy is often given.[6,7]
Radiation therapy.
Radiation therapy.
Intracavitary and interstitial radiation are administered to a dose of at least 75 Gy to the primary tumor.[1]
Sources: 1
For lesions in the lower third of the vagina, elective radiation therapy of 45 Gy to 50 Gy is given to the pelvic and/or inguinal lymph nodes.[1,9]
Combined local therapy in selected cases, which may include wide local excision, lymph node sampling, and interstitial therapy.[10]
Sources: 10
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
The treatment options for stages II, III, and IVa vaginal cancer have not been directly compared in randomized trials.[Level of evidence C2] As a result of differences in patient selection, expertise in treating local disease, and staging criteria, it is difficult to determine whether there are differences in disease control rates.
Sources: Level of evidence C2
Radiation therapy is the most common treatment for patients with stages II, III, and IVa vaginal cancer.
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Treatment options for stage II SCC and adenocarcinoma of the vagina, stage III SCC and adenocarcinoma of the vagina, and stage IVa SCC and adenocarcinoma of the vagina include:
Sources: stage II SCC and adenocarcinoma of the vagina · stage III SCC and adenocarcinoma of the vagina · stage IVa SCC and adenocarcinoma of the vagina
Radiation therapy.
Radiation therapy.
External-beam radiation therapy (EBRT) alone or in combination with interstitial and/or intracavitary brachytherapy.[1-5] For example, EBRT for a period of 5 to 6 weeks (including the pelvic lymph nodes) followed by an interstitial and/or intracavitary implant for a total tumor dose of 75 Gy to 80 Gy and a dose to the lateral pelvic wall of 55 Gy to 60 Gy.[1-3]
For lesions in the lower third of the vagina, elective radiation therapy of 45 Gy to 50 Gy is given to the pelvic and/or inguinal lymph nodes.[1,2,6]
Surgery.
Surgery.
Radical vaginectomy or pelvic exenteration is performed with or without radiation therapy.[7-10]
Chemoradiation.[11]
Sources: 11
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Treatment options for stage IVb SCC and adenocarcinoma of the vagina include:
Radiation therapy (for palliation of symptoms) with or without chemotherapy.
For patients with stage IVb disease, current therapy is inadequate. No established anticancer drugs have demonstrated clinical benefit, although patients are often treated with regimens used to treat cervical cancer.
Concurrent chemotherapy using fluorouracil or cisplatin-based therapy and radiation therapy is sometimes advocated on the basis of results extrapolated from cervical cancer management strategies.[1-3] Evidence is limited to small case series, and the incremental impact on patient survival and local disease control is not well defined.[Level of evidence C3] For more information, see Cervical Cancer Treatment.
Sources: 1 · 3 · Level of evidence C3 · Cervical Cancer Treatment
Because stage IVb vaginal cancer is rare, these patients are candidates for clinical trials to improve survival or local control. Information about ongoing clinical trials is available from the NCI website.
Sources: NCI website
Source: Vaginal Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 3, 2025. Captured 2026-09-09.
Patients with recurrent vaginal cancer have a very poor prognosis. Most recurrences occur in the first 2 years after treatment.
Some patients with centrally recurrent vaginal cancers are candidates for pelvic exenteration or radiation therapy. In a large series, only 5 of 50 patients with recurrence were salvaged using surgery or radiation therapy. All five of these salvaged patients originally presented with stage I or II disease and had tumor recurrence in the central pelvis.[1]
Sources: 1
No established anticancer drugs have demonstrated clinical benefit, although patients are often treated with regimens used to treat cervical cancer. If patients are eligible, participation in clinical trials should be considered. Information about ongoing clinical trials is available from the NCI website.
Sources: NCI website
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
The prognosis depends on the following:
Sources: prognosis
The stage of the cancer (whether it is in the vagina only or has spread to other areas).
Sources: stage
The size of the tumor.
Sources: tumor
The grade of tumor cells (how different they look from normal cells under a microscope).
Sources: grade
Where the cancer is within the vagina.
Whether there are signs or symptoms at diagnosis.
Sources: diagnosis
Whether the cancer has just been diagnosed or has recurred (come back).
Sources: recurred
Treatment options depend on the following:
The stage and size of the cancer.
Whether the cancer is close to other organs that may be damaged by treatment.
Sources: organs
Whether the tumor is made up of squamous cells or is an adenocarcinoma.
Whether the patient has a uterus or has had a hysterectomy.
Whether the patient has had past radiation treatment to the pelvis.
Sources: radiation treatment · pelvis
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
The cancer may come back in the vagina or in other parts of the body.
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
There are different types of treatment for patients with vaginal cancer.
The following types of treatment are used:
The following types of treatment are used:
Surgery
Radiation therapy
Chemotherapy
New types of treatment are being tested in clinical trials.
New types of treatment are being tested in clinical trials.
Immunotherapy
Radiosensitizers
Treatment for vaginal cancer may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Different types of treatments are available for patients with vaginal cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Sources: vaginal cancer · standard · clinical trials · research study · cancer
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Surgery is a treatment option for both vaginal intraepithelial neoplasia (VaIN) and vaginal cancer.
Sources: Surgery · vaginal intraepithelial neoplasia
The following types of surgery may be used to treat VaIN:
Laser surgery: A surgical procedure that uses a laser beam (a narrow beam of intense light) as a knife to make bloodless cuts in tissue or to remove a surface lesion such as a tumor.
Sources: Laser surgery · laser beam · tissue · lesion · tumor
Wide local excision: A surgical procedure that takes out the cancer and some of the healthy tissue around it.
Sources: Wide local excision
Vaginectomy: Surgery to remove all or part of the vagina. Skin grafts from other parts of the body may be needed to reconstruct the vagina.
Sources: Vaginectomy · vagina · Skin grafts · reconstruct
The following types of surgery may be used to treat vaginal cancer:
Wide local excision: A surgical procedure that takes out the cancer and some of the healthy tissue around it.
Sources: Wide local excision
Vaginectomy: Surgery to remove all or part of the vagina. Skin grafts from other parts of the body may be needed to reconstruct the vagina.
Sources: Vaginectomy · vagina
Total hysterectomy: Surgery to remove the uterus, including the cervix. If the uterus and cervix are taken out through the vagina, the operation is called a vaginal hysterectomy. If the uterus and cervix are taken out through a large incision (cut) in the abdomen, the operation is called a total abdominal hysterectomy. If the uterus and cervix are taken out through a small incision in the abdomen using a laparoscope, the operation is called a total laparoscopic hysterectomy.
Sources: Total hysterectomy · uterus · cervix · vaginal · hysterectomy · incision · abdomen · abdominal · laparoscope · laparoscopic
Lymph node dissection: A surgical procedure in which lymph nodes are removed and a sample of tissue is checked under a microscope for signs of cancer. This procedure is also called lymphadenectomy. If the cancer is in the upper vagina, the pelvic lymph nodes may be removed. If the cancer is in the lower vagina, lymph nodes in the groin may be removed.
Sources: Lymph node dissection · lymph nodes · microscope · signs · pelvic · groin
Pelvic exenteration: Surgery to remove the lower colon, rectum, bladder, cervix, vagina, and ovaries. Nearby lymph nodes are also removed. Artificial openings (stoma) are made for urine and stool to flow from the body into a collection bag.
Sources: Pelvic exenteration · colon · rectum · bladder · ovaries · stoma · urine · stool
After the doctor removes all the cancer that can be seen at the time of the surgery, some patients may be given radiation therapy after surgery to kill any cancer cells that are left. Treatment given after the surgery, to lower the risk that the cancer will come back, is called adjuvant therapy.
Sources: radiation therapy · cells · adjuvant therapy
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:
External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.
Sources: External radiation therapy
Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.
Sources: Internal radiation therapy · radioactive · seeds · catheters
The way the radiation therapy is given depends on the type and stage of the cancer being treated. External and internal radiation therapy are used to treat vaginal cancer, and may also be used as palliative therapy to relieve symptoms and improve quality of life.
Sources: stage · palliative therapy · symptoms · quality of life
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can affect cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.
Sources: Chemotherapy · drugs · injected · vein · systemic chemotherapy · cerebrospinal fluid · organ · cavity · regional chemotherapy
Topical chemotherapy for squamous cell vaginal cancer may be applied to the vagina in a cream or lotion.
Sources: Topical chemotherapy · squamous cell
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.
Sources: NCI website
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Immunotherapy is a treatment that uses the patient’s immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer.
Sources: Immunotherapy · immune system
Imiquimod is an immune response modifier that is being studied to treat vaginal lesions and is applied to the skin in a cream.
Sources: Imiquimod · immune response
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Radiosensitizers are drugs that make tumor cells more sensitive to radiation therapy. Combining radiation therapy with radiosensitizers may kill more tumor cells.
Sources: Radiosensitizers
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For information about side effects caused by treatment for cancer, visit our Side Effects page.
Sources: side effects · Side Effects
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Sources: clinical trial · standard treatment
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Sources: side effects
Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s clinical trials search webpage. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trials search · ClinicalTrials.gov
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Sources: diagnose
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of vaginal intraepithelial neoplasia (VaIN) may include the following:
Sources: vaginal intraepithelial neoplasia
Surgery (laser surgery after biopsy).
Sources: Surgery · laser surgery · biopsy
Surgery (wide local excision) with a skin graft.
Sources: wide local excision · skin graft
Surgery (partial or total vaginectomy) with or without a skin graft.
Sources: vaginectomy
Topical chemotherapy.
Sources: Topical chemotherapy
Internal radiation therapy.
Sources: Internal radiation therapy
A clinical trial of immunotherapy (imiquimod) applied to the skin.
Sources: clinical trial · immunotherapy · imiquimod
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of stage I squamous cell vaginal cancer lesions that are less than 0.5 centimeters thick may include the following:
Sources: stage I · squamous cell · lesions · centimeters
External radiation therapy, especially for large tumors or the lymph nodes near tumors in the lower part of the vagina.
Sources: External radiation therapy · tumors · lymph nodes · vagina
Internal radiation therapy.
Sources: Internal radiation therapy
Surgery (wide local excision or vaginectomy with vaginal reconstruction). Radiation therapy may be given after the surgery.
Sources: Surgery · wide local excision · vaginectomy · vaginal · Radiation therapy
Treatment of stage I squamous cell vaginal cancer lesions that are more than 0.5 centimeters thick may include the following:
Surgery:
Surgery:
For lesions in the upper third of the vagina, vaginectomy and lymph node dissection, with or without vaginal reconstruction.
Sources: lymph node dissection
For lesions in the lower third of the vagina, lymph node dissection.
Radiation therapy may be given after the surgery, which may include:
Radiation therapy may be given after the surgery, which may include:
External radiation therapy with or without internal radiation therapy.
Sources: External radiation therapy · internal radiation therapy
Internal radiation therapy.
For lesions in the lower third of the vagina, radiation therapy may be given to lymph nodes near tumors.
Treatment of stage I vaginal adenocarcinoma may include the following:
Sources: stage I vaginal · adenocarcinoma
Surgery (vaginectomy and hysterectomy with lymph node dissection). This may be followed by vaginal reconstruction and/or radiation therapy.
Sources: Surgery · vaginectomy · hysterectomy · lymph node dissection · vaginal · radiation therapy
Internal radiation therapy. External radiation therapy may also be given to the lymph nodes near tumors in the lower part of the vagina.
Sources: Internal radiation therapy · External radiation therapy · lymph nodes · tumors · vagina
A combination of therapies that may include wide local excision with or without lymph node dissection and internal radiation therapy.
Sources: therapies · wide local excision
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of stage II, stage III, and stage IVA vaginal cancer is the same for squamous cell cancer and adenocarcinoma. Treatment may include the following:
Sources: stage II · stage III · stage IVA vaginal cancer · squamous cell cancer · adenocarcinoma
Internal and/or external radiation therapy to the vagina. Radiation therapy may also be given to the lymph nodes near tumors in the lower part of the vagina.
Sources: Internal · external radiation therapy · vagina · Radiation therapy · lymph nodes · tumors · vagina
Surgery (vaginectomy or pelvic exenteration) with or without radiation therapy.
Sources: Surgery · vaginectomy · pelvic exenteration
Chemotherapy given with radiation therapy.
Sources: Chemotherapy
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of stage IVB vaginal cancer is the same for squamous cell cancer and adenocarcinoma. Treatment may include the following:
Sources: stage IVB vaginal cancer · squamous cell cancer · adenocarcinoma
Radiation therapy as palliative therapy, to relieve symptoms and improve the quality of life. Chemotherapy may also be given.
Sources: Radiation therapy · palliative therapy · symptoms · quality of life · Chemotherapy
Although no anticancer drugs have been shown to help patients with stage IVB vaginal cancer live longer, they are often treated with regimens used for cervical cancer. For more information, see Cervical Cancer Treatment.
Sources: regimens · cervical cancer · Cervical Cancer Treatment
Source: Vaginal Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 5, 2023. Captured 2026-09-09.
For information about the treatments listed below, see the Treatment Option Overview section.
Sources: Treatment Option Overview
Treatment of recurrent vaginal cancer may include the following:
Sources: recurrent · vaginal cancer
Surgery (pelvic exenteration).
Sources: Surgery · pelvic exenteration
Radiation therapy.
Sources: Radiation therapy
Although no anticancer drugs have been shown to help patients with recurrent vaginal cancer live longer, they are often treated with regimens used for cervical cancer. For more information, see Cervical Cancer Treatment.
Sources: regimens · cervical cancer · Cervical Cancer Treatment
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Cancer of the Cervix
ClinicalTrials.gov recordTreatment of Recurrent Vaginal Cancer
Treatment of Stage I Vaginal Cancer
Treatment of Stage II, Stage III, and Stage IVA Vaginal Cancer
Treatment of Stage IVb Vaginal Cancer
Vaginal Cancer